8,635 Shares in SPDR S&P Biotech ETF $XBI Acquired by Jessup Wealth Management Inc

Jessup Wealth Management Inc bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 8,635 shares of the exchange traded fund’s stock, valued at approximately $1,053,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its holdings in SPDR S&P Biotech ETF by 27.3% during the third quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after purchasing an additional 2,900,633 shares in the last quarter. Bessemer Group Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 13.5% in the fourth quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock valued at $225,965,000 after buying an additional 220,244 shares in the last quarter. Ameriprise Financial Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 40.5% in the third quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock valued at $122,906,000 after buying an additional 353,351 shares in the last quarter. LPL Financial LLC increased its holdings in shares of SPDR S&P Biotech ETF by 27.0% in the fourth quarter. LPL Financial LLC now owns 875,547 shares of the exchange traded fund’s stock valued at $106,755,000 after buying an additional 185,964 shares in the last quarter. Finally, Greenhouse Funds LLLP increased its holdings in shares of SPDR S&P Biotech ETF by 16.6% in the third quarter. Greenhouse Funds LLLP now owns 675,975 shares of the exchange traded fund’s stock valued at $67,733,000 after buying an additional 96,308 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $128.85 on Thursday. The stock has a market capitalization of $8.22 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 1 year low of $80.90 and a 1 year high of $139.19. The business’s fifty day moving average is $132.43 and its two-hundred day moving average is $126.96.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.